Search Results - "Jakobsen, Theresa"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The emerging roles of circRNAs in cancer and oncology by Kristensen, Lasse S., Jakobsen, Theresa, Hager, Henrik, Kjems, Jørgen

    Published in Nature reviews. Clinical oncology (01-03-2022)
    “…Over the past decade, circular RNAs (circRNAs) have emerged as a large class of primarily non-coding RNA molecules, many of which have key roles in cancer…”
    Get full text
    Journal Article
  2. 2

    Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory by Kristensen, Lasse S., Ebbesen, Karoline K., Sokol, Martin, Jakobsen, Theresa, Korsgaard, Ulrik, Eriksen, Ann C., Hansen, Thomas B., Kjems, Jørgen, Hager, Henrik

    Published in Nature communications (11-09-2020)
    “…Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as),…”
    Get full text
    Journal Article
  3. 3

    Genome-Wide Circular RNA Expression Patterns Reflect Resistance to Immunomodulatory Drugs in Multiple Myeloma Cells by Jakobsen, Theresa, Dahl, Mette, Dimopoulos, Konstantinos, Grønbæk, Kirsten, Kjems, Jørgen, Kristensen, Lasse Sommer

    Published in Cancers (20-01-2021)
    “…Immunomodulatory drugs (IMiDs), such as lenalidomide and pomalidomide, may induce significant remissions in multiple myeloma (MM) patients, but relapses are…”
    Get full text
    Journal Article
  4. 4

    The Transcriptional Landscape of Coding and Noncoding RNAs in Recurrent and Nonrecurrent Colon Cancer by Korsgaard, Ulrik, García-Rodríguez, Juan L., Jakobsen, Theresa, Ahmadov, Ulvi, Dietrich, Kim-Gwendolyn, Vissing, Stine M., Paasch, Thea P., Lindebjerg, Jan, Kjems, Jørgen, Hager, Henrik, Kristensen, Lasse S.

    Published in The American journal of pathology (01-08-2024)
    “…A number of patients with colon cancer with local or local advanced disease suffer from recurrence and there is an urgent need for better prognostic biomarkers…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma by Granau, Agnete Marie, Andersen, Pilar Aarøe, Jakobsen, Theresa, Taouxi, Konstantina, Dalila, Nawar, Mogensen, Johanne Bay, Kristensen, Lasse Sommer, Grønbæk, Kirsten, Dimopoulos, Konstantinos

    Published in Cancers (13-01-2023)
    “…Venetoclax, a BCL-2 inhibitor, has proven to be effective in several hematological malignancies, including mantle cell lymphoma (MCL). However, development of…”
    Get full text
    Journal Article